Louisiana State Employees Retirement System’s BioMarin Pharmaceuticals BMRN Stock Holding History

Louisiana State Employees Retirement System’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.24M	Buy	56,600 +900	+2%	+$49.3K	0.05%	359
2026 Q1	$3.15M	Buy	55,700 +2,500	+5%	+$146K	0.06%	323
2025 Q4	$3.16M	Sell	53,200 -300	-0.6%	-$16.3K	0.05%	315
2025 Q3	$2.9M	Sell	53,500 -500	-0.9%	-$28.6K	0.05%	346
2025 Q2	$2.97M	Buy	54,000 +600	+1%	+$35.3K	0.05%	310
2025 Q1	$3.77M	Buy	53,400 +500	+0.9%	+$33.6K	0.08%	205
2024 Q4	$3.48M	Buy	52,900 +100	+0.2%	+$6.7K	0.07%	238
2024 Q3	$3.71M	Sell	52,800 -900	-2%	-$75.2K	0.07%	229
2024 Q2	$4.42M	Buy	+53,700	New	+$4.47M	0.09%	168

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Louisiana State Employees Retirement System's BMRN Position: Q2 2026 in Review

Louisiana State Employees Retirement System increased its BioMarin Pharmaceuticals (BMRN) stake by 1.6% in Q2 2026, buying an estimated $49.3K and bringing the position to 56,600 shares worth $3.24M. The position accounts for 0.05% of the portfolio, ranked #359.

Louisiana State Employees Retirement System first reported a position in BMRN in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.42M in Q2 2024. 561 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Louisiana State Employees Retirement System held 56,600 shares of BioMarin Pharmaceuticals worth $3.24M as of Q2 2026.
Louisiana State Employees Retirement System bought 900 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $49.3K.
BioMarin Pharmaceuticals made up 0.05% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #359 holding.
Louisiana State Employees Retirement System first reported a position in BioMarin Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Louisiana State Employees Retirement System's BioMarin Pharmaceuticals position peaked at $4.42M in Q2 2024.
561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.